首頁 > 市場調查報告書 > 材料

聚合物

市場調查報告書

商品編碼

1521396

全球血液相容性聚合物市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Blood Compatible Polymers Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 135 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球血液相容聚合物市場需求預計將從 2023 年的 27.1 億美元達到 2032 年近 92.7 億美元的市場規模，2024-2032 年研究期間複合年成長率為 14.63%。

血液相容性聚合物是專門設計的材料，旨在與血液安全地相互作用，而不會引起不良反應。這些聚合物用於導管、心臟瓣膜和血管移植物等醫療器械。它們的生物相容性確保它們在與血液接觸時不會引發凝血、免疫反應或溶血。它們經過精心設計，無毒、抗蛋白質吸附且機械耐用。聚合物科學的進步促進了這些材料的開發，在確保各種血液接觸醫療器材的安全性和有效性方面發揮關鍵作用。

市場動態

血液相容性聚合物市場是由生物醫學工程的進步所推動的，旨在提高與血液接觸的醫療設備的安全性和有效性。當用於導管、血管移植物和心臟瓣膜等裝置時，這些聚合物旨在防止血液凝固（血栓形成）和免疫反應。表面改質技術和聚合物化學的創新使得能夠開發模仿自然組織生物相容性的生物材料，從而降低不良反應的風險並提高設備性能。促進病患安全和在醫療器材製造中採用生物相容性材料的監管措施進一步刺激了市場成長。

此外，心血管疾病和慢性腎臟疾病的盛行率不斷上升，需要長期使用血液接觸裝置，這推動了對可靠且耐用的血液相容性聚合物的需求。學術機構、醫療保健提供者和聚合物製造商之間的合作研究旨在解決與醫療設備使用相關的感染控制和血栓栓塞併發症等挑戰，促進市場的持續創新。此外，全球醫療保健基礎設施投資的增加和醫療保健支出的增加，透過增加採用生物相容性材料的先進醫療和外科手術的可及性，支持市場擴張。然而，開發和生產血液相容性聚合物的高成本可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球血液相容性聚合物市場的各個細分市場進行了包容性評估。血液相容性聚合物產業的成長和趨勢為本研究提供了整體方法。

市場區隔

血液相容性聚合物市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按類型

聚氯乙烯
聚四氟乙烯
聚醚碸
聚乙烯
聚醚醚酮
聚碸
聚丙烯

按申請

生物醫學和血液接觸設備
牙科
藥物輸送

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲血液相容聚合物市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。血液相容性聚合物市場的主要參與者包括AdvanSource Biomaterials Corporation、Sanofi SA、Baxter International Inc.、ASM International、Biomaterial USA LLC.、Eastman Chemical Company、Evonik Industries AG、The Dow Chemical Company、江蘇Senolo 醫療科技有限公司。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：血液相容性聚合物公司的競爭格局

血液相容性聚合物市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
AdvanSource Biomaterials Corporation

公司簡介
公司收入
產品
最近的發展

Sanofi SA

公司簡介
公司收入
產品
最近的發展

Baxter International Inc.

公司簡介
公司收入
產品
最近的發展

ASM International

公司簡介
公司收入
產品
最近的發展

Biomaterial USA LLC.

公司簡介
公司收入
產品
最近的發展

Eastman Chemical Company

公司簡介
公司收入
產品
最近的發展

Evonik Industries AG

公司簡介
公司收入
產品
最近的發展

The Dow Chemical Company

公司簡介
公司收入
產品
最近的發展

Jiangsu Senolo Medical Technology Co Ltd.

公司簡介
公司收入
產品
最近的發展

TOPAS Advanced Polymers Gmbh

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112115221

The global demand for Blood Compatible Polymers Market is presumed to reach the market size of nearly USD 9.27 Billion by 2032 from USD 2.71 Billion in 2023 with a CAGR of 14.63% under the study period 2024-2032.

Blood-compatible polymers are specialized materials designed to interact safely with blood without causing adverse reactions. These polymers are used in medical devices like catheters, heart valves, and vascular grafts. Their biocompatibility ensures they do not trigger clotting, immune responses, or hemolysis when in contact with blood. They are engineered to be nontoxic, resistant to protein adsorption, and mechanically durable. Advances in polymer science enable the development of these materials, which play a critical role in ensuring the safety and efficacy of various blood-contacting medical devices.

MARKET DYNAMICS

The market for blood compatible polymers is driven by advancements in biomedical engineering aimed at improving the safety & efficacy of medical devices that come into contact with blood. When used in devices such as catheters, vascular grafts, and heart valves, these polymers are designed to prevent blood clotting (thrombosis) and immune reactions. Innovations in surface modification techniques and polymer chemistry enable the development of biomaterials that mimic the biocompatibility of natural tissues, reducing the risk of adverse reactions and enhancing device performance. Regulatory initiatives promoting patient safety and the adoption of biocompatible materials in medical device manufacturing further stimulate market growth.

Additionally, the rising prevalence of cardiovascular diseases & chronic kidney disorders necessitating prolonged use of blood-contacting devices drives demand for reliable and durable blood compatible polymers. Collaborative research efforts between academic institutions, healthcare providers, and polymer manufacturers aim to address challenges such as infection control and thromboembolic complications associated with medical device use, fostering continuous innovation in the market. Moreover, growing investments in healthcare infrastructure and rising healthcare expenditure globally support market expansion by increasing accessibility to advanced medical treatments and surgical interventions employing biocompatible materials. However, the high cost of developing and producing blood compatible polymers may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Blood Compatible Polymers. The growth and trends of Blood Compatible Polymers industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Blood Compatible Polymers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Polyvinylchloride
Polytetrafluoroethylene
Polyethersulfone
Polyethylene
Polyetheretherketone
Polysulfone
Polypropylene

By Application

Biomedical & Blood Contacting Devices
Dental
Drug Delivery

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Blood Compatible Polymers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Blood Compatible Polymers market include AdvanSource Biomaterials Corporation, Sanofi S.A., Baxter International Inc., ASM International, Biomaterial USA LLC., Eastman Chemical Company, Evonik Industries AG, The Dow Chemical Company, Jiangsu Senolo Medical Technology Co Ltd., TOPAS Advanced Polymers Gmbh. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BLOOD COMPATIBLE POLYMERS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BLOOD COMPATIBLE POLYMERS MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Polyvinylchloride Historic and Forecast Sales By Regions
5.4. Polytetrafluoroethylene Historic and Forecast Sales By Regions
5.5. Polyethersulfone Historic and Forecast Sales By Regions
5.6. Polyethylene Historic and Forecast Sales By Regions
5.7. Polyetheretherketone Historic and Forecast Sales By Regions
5.8. Polysulfone Historic and Forecast Sales By Regions
5.9. Polypropylene Historic and Forecast Sales By Regions

6. GLOBAL BLOOD COMPATIBLE POLYMERS MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Biomedical & Blood Contacting Devices Historic and Forecast Sales By Regions
6.4. Dental Historic and Forecast Sales By Regions
6.5. Drug Delivery Historic and Forecast Sales By Regions

7. GLOBAL BLOOD COMPATIBLE POLYMERS MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE BLOOD COMPATIBLE POLYMERS COMPANIES

8.1. Blood Compatible Polymers Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF BLOOD COMPATIBLE POLYMERS INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. AdvanSource Biomaterials Corporation
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Sanofi S.A.
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Baxter International Inc.
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. ASM International
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Biomaterial USA LLC.
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Eastman Chemical Company
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Evonik Industries AG
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. The Dow Chemical Company
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Jiangsu Senolo Medical Technology Co Ltd.
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. TOPAS Advanced Polymers Gmbh
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments